It belongs to a class of medicines called GLP-1 receptor agonists , which were originally developed for type 2 diabetes management but have proven highly effective for weight loss
Think of peptides as tiny chemical messengers
Its approach combines: Psychology-based daily lessons and mindset tools grounded in behavioral science Coaching and accountability support Food, weight, and habit tracking in a single app Access to licensed clinicians through the Noom Med program Multiple medical pathways, including full-dose GLP-1s, microdose GLP-1s, and oral weight-loss medications Ongoing guidance for side-effect management, appetite changes, and long-term habit maintenance Within Noom Med, prescription optionsincluding injectables, oral medications, and microdose alternativesare integrated directly into the behavior-change program
Opportunity Beyond Diabetes GLP-1 and dual GIP/GLP-1 analogs are now being evaluated for: Cardiovascular disease prevention Fatty liver disease (NASH/NAFLD) Neurodegenerative disorders This pipeline expansion is widening the market for high-purity peptide APIs exponentially
Our military and veteran families have sacrificed so much and deserve to live in communities that value them, invest in them, and understand the unique cultural, environmental, and battleground experiences they share in service to their country
